ELCC 2016 | Characterizing tumor-infiltrating lymphocytes in resectable early stage NSCLC
David Carbone
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 13–16 April 2016, David Carbone, MD, PhD, from The Ohio State University Wexner Medical Center, Columbus, OH, discusses the characterization of tumor-infiltrating lymphocytes in resectable early stage non-small cell lung cancer (NSCLC) and the application of this understanding for the development of immunotherapy in early stage disease.
Similar topics
Related videos

Accelerate, Coordinate, Evaluate (ACE) cancer care: the CRUK programme streamlining the care pathway
Sara Hiom

Lung cancer screening in the UK: CRUK, UK NSC, Public Health England & NHS England
Sara Hiom

The Recovery Package in lung cancer
Josie Roberts

Single-port VATS for NSCLC: outcomes related to smoking status
John Edwards

Psychological impact of lung cancer screening
Mamta Ruparel
et al.
More from David Carbone